Mankind Pharma to sell its OTC business on slump sale basis: Some of the key OTC products by Mankind Pharma include the anti-inflammatory and anti-bacterial ...
financialexpress.com/healthcare/pharma-healthcare/mankind-pharma-to-sell-its-otc-business-on-slump-sale-basis/3444885/
Commonly-used painkiller Nimesulide and antibiotic Cefuroxime can lead to serious skin disorders; Govt issues alert
financialexpress.com/healthcare/pharma-healthcare/commonly-used-painkiller-nimesulide-and-antibiotic-cefuroxime-can-lead-to-serious-skin-disorders-govt-issues-alert/3454719/
ChrysCapital pares 2.9 per cent stake in Mankind Pharma for Rs 2,469 crore: According to the bulk deal data available on the NSE, Beige Ltd offloaded more than 1 ...
financialexpress.com/market/chryscapital-pares-2-9-per-cent-stake-in-mankind-pharma-for-rs-2469-crore-bkg-3437436/
#StocksToWatch | Here are top stocks that could be in focus today!
Read here: www.livemint.com/market/stock-market-news/stocks-to-watch-religare-mahindra-lifespace-eicher-mankind-pharma-adani-ports-lupin-11711419769530.html
New marketing code for drugs stirs debate: Govt's latest bid aimed at cutting “promotional costs” of medicines and reducing prices.
financialexpress.com/healthcare/pharma-healthcare/new-marketing-code-for-drugs-stirs-debate/3437488/
Stocks to watch on March 26: UltraTech, Mankind Pharma, RIL, RVNL, Lupin: Stocks to Watch on March 26, 2024: Reliance Industries acquired a 100 per cent stake in ...
business-standard.com/markets/news/stocks-to-watch-on-march-26-ultratech-mankind-pharma-ril-rvnl-lupin-124032600073_1.html
Mankind Pharma promoters to divest stake to comply with MPS norms; read to know more
financialexpress.com/market/mankind-pharma-promoters-to-divest-stake-to-comply-with-mps-norms-read-to-know-more-3387139/
India's Mankind Pharma beats Q3 profit estimates on strong demand: Mankind Pharma (MNKI.NS), one of India's leading condom makers, posted a bigger-than-expected ...
reuters.com/world/india/indias-mankind-pharma-beats-q3-profit-estimates-strong-demand-2024-01-31/
Stock of this pharma company has nearly doubled against its issue price: Mankind hit record high of Rs 2,132.10, rallied 8% in intra-day trade and zoomed 97% ...
business-standard.com/markets/news/stock-of-this-pharma-company-has-nearly-doubles-against-its-issue-price-124010200351_1.html
Paid articlePaid
India IPOs Marks Record Year With Mankind Pharma, Tata Technologies, More: A Buyer’s Market
bloomberg.com/news/newsletters/2023-11-30/india-ipos-marks-record-year-with-mankind-pharma-tata-technologies-more
India IPOs Marks Record Year With Mankind Pharma, Tata Technologies, More: A Buyer’s Market
bloomberg.com/news/newsletters/2023-11-30/india-ipos-marks-record-year-with-mankind-pharma-tata-technologies-more
Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles: The delayed season not only affected anti-infectives but also related sub-therapies ...
business-standard.com/companies/interviews/mankind-pharma-sees-21-profit-surge-in-q2-despite-consumer-health-hurdles-123111200414_1.html
Paid articlePaid
With India's Biggest IPO In The Rearview Mirror, Mankind Pharma Sets Eyes On New Ambition - Forbes India
forbesindia.com/article/billionaires/with-indias-biggest-ipo-in-the-rearview-mirror-mankind-pharma-sets-eyes-on-new-ambition/89687/1
Street signs: Bulls charge ahead, IPO stars shine bright, and more: Shares of Mankind Pharma, SBFC Finance, and Fusion Micro Finance are likely to attract ...
business-standard.com/markets/news/street-signs-bulls-charge-ahead-ipo-stars-shine-bright-and-more-123110500521_1.html
Paid articlePaid
From Forbes India 30 Under 30 nominations forms to the rise of luxury homestays, here are our most-read stories of the week
forbesindia.com/article/news/from-forbes-india-30-under-30-nominations-forms-to-the-rise-of-luxury-homestays-here-are-our-mostread-stories-of-the-week/89759/1
Grapevine: Mankind in fray for Ayurveda firm; Adani may sell stake in consumer arm
vccircle.com/grapevinemankind-in-fray-for-ayurveda-firm-adani-may-sell-stake-in-consumer-arm
Manforce condoms maker Mankind Pharma posts Q2 profit rise on higher sales: India's Mankind Pharma (MNKI.NS) posted an over 19% rise in second-quarter profit on ...
reuters.com/world/india/manforce-condoms-maker-mankind-pharma-posts-q2-profit-rise-higher-sales-2023-10-31/
Stocks in News: आज फोकस में रहेंगे TCS, L&T, Tech Mahindra, Tata Power, Coal India समेत ये स्टॉक, इंट्राडे में दिखेगा एक्शन
hindi.financialexpress.com/business-news/ril-infosys-hul-icici-bank-union-bank-hdfc-bank-vedanta-among-top-buzzing-stocks-today-21-july-2023/3064130/
#ForbesIndiaRichList | Pharma brothers Ramesh and Rajeev Juneja got a handsome 64% boost from the May listing of their Mankind Pharma, which took their net worth to $6 ... Show more www.forbesindia.com/lists/rich-list-2023/
Lock-in period for 27 companies set to expire in 2 months; 23 of 27 firms trading above the issue price
financialexpress.com/market/lock-in-period-for-27-companies-set-to-expire-in-2-months-23-of-27-firms-trading-above-the-issue-price/3214139/
Margin growth hopes give hospital, pharma IPOs booster shot: Over Rs 15,000 cr of IPOs expected in 2023
financialexpress.com/market/ipo-news-margin-growth-hopes-give-hospital-pharma-ipos-booster-shot-3224340/
Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth: Mankind Pharma Q1 Results: Juneja also highlighted a 43 per cent YoY increase in Ebitda as a ...
business-standard.com/companies/news/mankind-pharma-pat-up-66-in-q1-to-rs-494-crore-on-revenue-growth-123080200759_1.html
Manforce condoms maker Mankind Pharma posts 66% jump Q1 profit: India's Mankind Pharma Ltd (MNKI.NS) posted a 66% jump in June-quarter profit on Wednesday ...
reuters.com/business/healthcare-pharmaceuticals/manforce-condoms-maker-mankind-pharma-posts-66-jump-q1-profit-2023-08-02/
Mankind Pharma reports 66% surge in Q1 profit: Mankind Pharma reports 66% surge in Q1 profit
wionews.com/business-economy/mankind-pharma-reports-66-surge-in-q1-profit-621856
Condom Maker’s Success Boosts Hopes of More Consumer IPOs in India: The stellar performance of Mankind Pharma Ltd. since its listing in Mumbai in May could ...
bloomberg.com/news/articles/2023-07-04/condom-maker-success-boosts-hopes-of-more-consumer-ipos-in-india
Nifty Pharma, FMCG indices trading near key resistance zone: According to Ravi Nathani, an independent technical analyst, the Nifty FMCG index is expected to ...
business-standard.com/markets/news/nifty-pharma-fmcg-indices-trading-near-key-resistance-zone-123062100094_1.html
Condom Maker Draws Rush of Buy Calls on 60% Jump Since India IPO: Mankind Pharma Ltd. has garnered the most analyst coverage of any new Indian stock in at least ...
bloomberg.com/news/articles/2023-06-20/condom-maker-draws-rush-of-buy-calls-on-57-jump-since-india-ipo
Meet Poonam Juneja, Director at Mankind Pharma & wife of Ramesh Juneja who sold her Delhi property for Rs 91 crore: Know about her lifestyle & family
financialexpress.com/lifestyle/meet-poonam-juneja-director-at-mankind-pharma-wife-of-ramesh-juneja-who-sold-her-delhi-property-for-rs-91-crore-know-about-her-lifestyle-family/3107067/
Stocks to watch: Coal India, Mankind Pharma, EID Parry, India Pesticides: Stocks to watch on June 1, 2023: From Coal India to Mankind Pharma, here are top stocks ...
business-standard.com/markets/news/stocks-to-watch-today-coal-india-mankind-pharma-eid-parry-india-pesticides-123060100105_1.html
Mankind Pharma scales new high; rallies 11% in 3 days post Q4 earnings beat: Currently, the stock was quoting 40 per cent higher over its issue price of Rs 1,080 ...
business-standard.com/markets/news/mankind-pharma-hits-new-high-since-listing-stock-surges-8-123060200405_1.html
Meet Sandeep Engineer, Founder of Astral Limited: Know about his career, lifestyle & net worth
financialexpress.com/lifestyle/meet-sandeep-engineer-founder-of-astral-limited-know-about-his-career-lifestyle-net-worth/3109109/
Meet Sandeep Engineer, Founder of Astral Limited: Know about his career, lifestyle & net worth
financialexpress.com/lifestyle/meet-sandeep-engineer-founder-of-astral-limited-know-about-his-career-lifestyle-net-worth/3109109/
Condom Maker Surges 23% in Mumbai Debut After a $529 Million IPO: Mankind Pharma Ltd. rallied almost 23% on its first day of trading in Mumbai after raising 43 ...
bloomberg.com/news/articles/2023-05-09/condom-maker-mankind-pharma-to-debut-in-mumbai-after-a-529-million-ipo
More IPOs need to deliver listing pop to revive retail interest: Analysts: IPOs: Analysts say retail investors' enthusiasm fizzled out post the muted listing of ...
business-standard.com/markets/news/more-ipos-need-to-deliver-listing-pop-to-revive-retail-interest-analysts-123051500277_1.html
#MarketOpeningBell | Sensex rallies 391 points to 61,446 in early trade; Nifty rises 107 points to 18,176.
Catch all the LIVE updates here bit.ly/3LFfxSF #sensex #nifty #MarketsWithBS #sharemarket ... Show more #StockMarket
India tax dept searches Mankind Pharma's office -source: India's income tax department is conducting searches at Mankind Pharma Ltd's (MNKI ...
reuters.com/world/india/india-tax-dept-searches-mankind-pharmas-office-cnbc-tv18-2023-05-11/
India tax dept searches Mankind Pharma's office -source: India's income tax department is conducting searches at Mankind Pharma Ltd's (MNKI ...
reuters.com/world/india/india-tax-dept-searches-mankind-pharmas-office-cnbc-tv18-2023-05-11/
Mankind Pharma IPO में ‘सब्सक्राइब’ की सलाह, शेयर का वैल्युएशन बेहतर, लिस्टिंग के बाद आ सकती है तेजी
financialexpress.com/hindi/business-news/mankind-pharma-ipo-get-subscription-rating-why-you-should-invest-valuation-of-stock-attractive/3060232/
Mankind Pharma IPO to open on April 25; all OFS, no fresh issue, 4 crore shares on sale
financialexpress.com/market/ipo-news/mankind-pharma-ipo-to-open-on-april-25-all-ofs-no-fresh-issue-4-crore-shares-on-sale/3051889/
Stocks in News: फोकस में रहेंगे Tata Motors, Wipro, M&M, UCO Bank समेत ये स्टॉक, इंट्राडे में दिखेगा एक्शन
hindi.financialexpress.com/business-news/eicher-motors-tata-motors-dmart-vedanta-ril-adani-enterprises-ongc-airtel-among-top-buzzing-stocks-today-12-may-2023/3038583/
Meet Ramesh Juneja, chairman of Mankind Pharma; Know about his Rs 34,500 crore net worth, career & more
financialexpress.com/lifestyle/meet-ramesh-juneja-chairman-of-mankind-pharma-know-about-his-rs-34500-crore-net-worth-career-more/3062874/
#MankindPharma IPO to open next week: Check here for price band, GMP and other detailsbit.ly/3osvFPq #IPO #stockmarket #markets #indianstockmarket
Upcoming IPOs in May: Krishca Strapping IPO, Remus Pharma IPO to hit Dalal Street in May | Mint
livemint.com/market/ipo/upcoming-ipos-in-may-krishca-strapping-ipo-remus-pharma-ipo-to-hit-dalal-street-in-may-11684065184603.html
Paid articlePaid
Stocks to Watch on May 12: Adani Total, RIL, TaMo, ONGC, Vedanta, Mankind: Top 10 | Stocks to Watch today | Business Standard | May 11, 2023: Mankind Pharma has ...
business-standard.com/markets/news/stocks-to-watch-today-may-12-2023-adani-total-ril-tamo-ondc-vedanta-mankind-123051200105_1.html
Mahanagar Gas shares rally, Mankind Pharma IPO soars, Rupee weakens amid crude rebound. A short 🧵on the top trending stories of the hour. #MidMarketUpdate
Condom maker becomes benchmark for Indian stock market: Condom maker Mankind Pharma raised half a billion dollars on its IPO. As of today, Tuesday ...
diepresse.com/6285483/kondomhersteller-wird-zum-gradmesser-fuer-den-indischen-aktienmarkt
Delhi-based #MankindPharma to brand its medicines with API quality mark.@sohinidastweets reportsbit.ly/3Uo1dSN #DMF #USFDA #PharmaSector
Mankind Pharma IPO’s success raises revival hopes for moribund public issue market
financialexpress.com/market/ipo-news/mankind-pharma-ipos-success-raises-revival-hopes-for-moribund-public-issue-market/3066418/
Mankind Pharma 1529% सब्सक्राइब, लेकिन रिटेल निवेशक रहे दूर, ग्रे मार्केट में भाव बिगड़ा
hindi.financialexpress.com/business-news/mankind-pharma-ipo-gets-robust-response-from-qib-and-nii-but-retail-investors-are-alert-check-subscription-status/3034175/
Abbott recalls a batch of thyroid disorder drug for labelling error: Abbott Thyronorm Recalled: Thyronorm has no quality issue, mislabeled batch was invoiced in ...
business-standard.com/companies/news/abbott-recalls-a-batch-of-thyroid-drug-thyronorm-for-labelling-error-123042600866_1.html
Paid articlePaid
Mankind Pharma eyes Rs 4,700 crore through IPO: “The company is looking to launch the IPO by the end of this month, depending on regulatory approvals ...
financialexpress.com/market/ipo-news/mankind-pharma-eyes-rs-4700-crore-through-ipo/3034193/
Passionate trainer and a lifelong learner Farhat Umar has made it to Forbes India’s list of #Top30TalentLeaders .
To know more about this outstanding talent leader: ... Show more www.facebook.com/Indeed/ #HR #TalentAcquisition #Awards #talentmanagement #talentdevelopment #talent #CHRO #humanresources #partnered
Mankind Pharma invests in Actimed Therapeutics for clinical developments in cancer
financialexpress.com/healthcare/news-healthcare/mankind-pharma-invests-in-actimed-therapeutics-for-clinical-developments-in-cancer/2957485/
Mankind Pharma reduces price of its heart failure drug by 70 percent in India: Studies show that heart failure claims more than 17.9 million lives every year ...
financialexpress.com/healthcare/pharma-healthcare/mankind-pharma-reduces-price-of-its-heart-failure-drug-by-70-percent-in-india/2959704/
Structural triggers missing in generics: India is among the top 5 suppliers of pharma products in US market
financialexpress.com/healthcare/pharma-healthcare/structural-triggers-missing-in-generics/2941859/
Mankind Pharma’s HealthOK revamps its multivitamin tablet: According to the company, the new consumer-engaging and attractive packaging is intended to symbolise ...
financialexpress.com/healthcare/wellness/mankind-pharmas-healthok-revamps-its-multivitamin-tablet/2930682/
Mankind Pharma forays into pet-care segment; Launches dog food: According to the company, India has seen growth in pet ownership in the last decade which ...
financialexpress.com/healthcare/news-healthcare/mankind-pharma-forays-into-pet-care-segment-launches-dog-food/2921570/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics